AlerisLife (NASDAQ: ALR)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.210 | -0.280 | -0.0700 | ||||
REV | 179.150M | 171.123M | -8.027M |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.310 | ||||||
REV | 185.210M | 173.143M | -12.067M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of AlerisLife (NASDAQ: ALR) through any online brokerage.
Other companies in AlerisLife’s space includes: Cano Health (NYSE:CANO), Universal Health Services (NYSE:UHS), Encompass Health (NYSE:EHC), Acadia Healthcare Co (NASDAQ:ACHC) and HCA Healthcare (NYSE:HCA).
The latest price target for AlerisLife (NASDAQ: ALR) was reported by B. Riley Securities on Wednesday, May 11, 2022. The analyst firm set a price target for 1.50 expecting ALR to rise to within 12 months (a possible 29.31% upside). 1 analyst firms have reported ratings in the last year.
The stock price for AlerisLife (NASDAQ: ALR) is $1.16 last updated August 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for AlerisLife.
AlerisLife’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for AlerisLife.
AlerisLife is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.